Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ABNB | BKNG |
|---|---|---|
| Price | $150.44 | $156.77 |
| Change today | ▲ 0.57% | ▲ 0.56% |
| Market cap | $90.08B | $117.79B |
| Return, 3 months | +4.2% | -13.3% |
| Return, year to date | +10.8% | -26.3% |
| Return, 1 year | +22.2% | -28.4% |
| P/E (TTM) | 34.3 | 17.4 |
| P/B | 11.6 | -10.9 |
| P/E percentile vs own 5y | 67th | 0th |
| Dividend yield | – | 1.03% |
| Revenue growth (YoY, latest qtr) | +16.5% | +8.1% |
| Net profit growth (YoY) | +27.1% | +117.9% |
| Gross margin | 82.9% | – |
| Operating margin | 20.8% | 34.5% |
| Net margin | 20.4% | 25.5% |
| Return on equity | 34.5% | – |
| Analyst target vs. price | +26.7% | +51.4% |
| Analyst buy share | 65% | 81% |
| RSI (14) | 29 | 22 |
| 30-day volatility | 31.8% | 33.9% |
| Max drawdown, 1 year | -19.0% | -30.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.